Overview Financials News + Filings Key Docs Charts Ownership
|
In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
Revenues: |
Non-US | 1,133.1 | 1,192.9 | 959.9 | 886.3 | 902.4 | | | |
Australia | 380.9 | 391.7 | 321.9 | 290.4 | 315.1 | 301.1 | 252.5 | 228.4 |
New Zealand | 88.1 | 115.9 | 81.9 | 72.2 | 79.1 | 76.8 | 73.3 | 61.4 |
Other | 2,175.0 | 1,914.2 | 1,545.0 | 1,357.9 | 1,210.0 | 1,676.6 | 1,595.8 | 1,438.4 |
Total revenues | 3,777.1 | 3,614.7 | 2,908.7 | 2,606.8 | 2,506.6 | 2,054.5 | 1,921.6 | 1,728.2 |
Revenue growth [+] | 4.5% | 24.3% | 11.6% | 4.0% | 22.0% | 6.9% | 11.2% | 4.3% |
Non-US | -5.0% | 24.3% | 8.3% | -1.8% | | | | |
Australia | -2.8% | 21.7% | 10.8% | -7.8% | 4.6% | 19.2% | 10.6% | -14.7% |
New Zealand | -24.0% | 41.5% | 13.4% | -8.7% | 3.0% | 4.8% | 19.4% | -5.1% |
Other Countries | -2.1% | 21.5% | 10.4% | 2.7% | 247.4% | -4.9% | -4.1% | 4.2% |
Cost of goods sold | 2,465.1 | 2,301.2 | 1,857.0 | 1,673.1 | 1,675.6 | 1,324.3 | 1,246.9 | 1,096.0 |
Gross profit | 1,312.0 | 1,313.5 | 1,051.7 | 933.7 | 831.0 | 730.2 | 674.7 | 632.2 |
Gross margin | 34.7% | 36.3% | 36.2% | 35.8% | 33.2% | 35.5% | 35.1% | 36.6% |
Selling, general and administrative | 494.0 | 461.2 | 389.6 | 415.8 | 403.6 | 311.3 | 291.6 | 254.2 |
Research and development | 39.6 | 38.0 | 34.3 | 32.8 | 37.9 | 33.3 | 30.3 | 29.5 |
Other operating expenses | 37.0 | 131.7 | 143.9 | 58.2 | 22.0 | 156.4 | -40.4 | -5.5 |
EBITDA [+] | 914.0 | 844.4 | 618.9 | 558.4 | 486.9 | 321.2 | 476.4 | 433.8 |
EBITDA growth | 8.2% | 36.4% | 10.8% | 14.7% | 51.6% | -32.6% | 9.8% | 6.9% |
EBITDA margin | 24.2% | 23.4% | 21.3% | 21.4% | 19.4% | 15.6% | 24.8% | 25.1% |
Depreciation | 168.8 | 158.3 | 132.4 | 128.4 | 113.3 | 91.1 | 83.2 | 79.8 |
EBITA | 745.2 | 686.1 | 486.5 | 430.0 | 373.6 | 230.1 | 393.2 | 354.0 |
EBITA margin | 19.7% | 19.0% | 16.7% | 16.5% | 14.9% | 11.2% | 20.5% | 20.5% |
Amortization of intangibles | 3.8 | 3.5 | 2.6 | 3.1 | 6.1 | 0.9 | | |
EBIT [+] | 741.4 | 682.6 | 483.9 | 426.9 | 367.5 | 229.2 | 393.2 | 354.0 |
EBIT growth | 8.6% | 41.1% | 13.4% | 16.2% | 60.3% | -41.7% | 11.1% | 5.7% |
EBIT margin | 19.6% | 18.9% | 16.6% | 16.4% | 14.7% | 11.2% | 20.5% | 20.5% |
Non-recurring items [+] | | | 11.1 | 84.4 | 15.9 | | | |
Asset impairment | | | 11.1 | 84.4 | 15.9 | | | |
Interest income, net [+] | 30.7 | 39.3 | 47.8 | 54.4 | -50.1 | -29.5 | -27.5 | -25.6 |
Interest expense | | | | | 50.1 | 32.9 | 28.5 | 26.6 |
Interest income | 30.7 | 39.3 | 47.8 | 54.4 | | 3.4 | 1.0 | 1.0 |
Other income (expense), net [+] | -48.6 | -78.8 | -108.6 | -108.9 | -0.9 | -25.4 | 1.3 | 2.1 |
Gain (loss) on debt retirement | | | 13.1 | | -1.0 | -26.1 | | |
Other | 12.8 | -0.2 | 0.1 | -0.1 | 0.1 | 0.7 | 1.3 | 2.1 |
Pre-tax income | 723.5 | 643.1 | 412.0 | 288.0 | 300.6 | 174.3 | 367.0 | 330.5 |
Income taxes | 211.5 | 184.0 | 149.2 | 46.5 | 71.8 | 28.2 | 90.5 | 86.1 |
Tax rate | 29.2% | 28.6% | 36.2% | 16.1% | 23.9% | 16.2% | 24.7% | 26.1% |
Net income | 512.0 | 459.1 | 262.8 | 241.5 | 228.8 | 146.1 | 276.5 | 244.4 |
Net margin | 13.6% | 12.7% | 9.0% | 9.3% | 9.1% | 7.1% | 14.4% | 14.1% |
|
Basic EPS [+] | $1.15 | $1.03 | $0.59 | $0.55 | $0.52 | $0.33 | $0.62 | $0.55 |
Growth | 11.5% | 74.2% | 8.6% | 5.4% | 56.4% | -47.0% | 13.8% | -16.2% |
Diluted EPS [+] | $1.15 | $1.03 | $0.59 | $0.54 | $0.52 | $0.33 | $0.62 | $0.55 |
Growth | 11.6% | 74.5% | 8.5% | 5.3% | 56.4% | -47.0% | 14.0% | -16.3% |
|
Dividends per share [+] | $0.29 | $1.09 | | $0.36 | $0.39 | $0.40 | $0.40 | $0.55 |
Growth | -73.2% | | -100.0% | -8.0% | -3.2% | 0.7% | -27.9% | -36.9% |
|
Shares outstanding (basic) [+] | 445.1 | 444.9 | 443.7 | 442.6 | 441.9 | 441.2 | 442.7 | 445.3 |
Growth | 0.0% | 0.3% | 0.2% | 0.2% | 0.2% | -0.3% | -0.6% | 0.1% |
Shares outstanding (diluted) [+] | 445.6 | 445.9 | 445.4 | 444.1 | 443.0 | 442.3 | 443.9 | 447.2 |
Growth | -0.1% | 0.1% | 0.3% | 0.2% | 0.2% | -0.4% | -0.7% | 0.2% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|